Cowen And Company »

Biohaven shares owned by Cowen And Company

Quarter-by-quarter ownership of Biohaven (BHVN) shares owned by Cowen And Company from 13F filings

Historical chart of Cowen And Company investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by Cowen And Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by Cowen And Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.4M 78k 42.80
2022-09-30 $289k 46k 6.30

More positions owned by Cowen And Company

NVIDIA Corporation (NVDA)
Ptc Therapeutics I (PTCT)
Coinbase Global Com Cl A (COIN)
Avidity Biosciences Ord (RNA)
Sirius Xm Holdings (SIRI)
Tarsus Pharmaceuticals (TARS)
Churchill Capital Corp Vii Com Cl A (CVII)
Immunocore Hldgs Ads (IMCR)
Select Sector Spdr Tr Energy (XLE)
Rocket Pharmaceuticals (RCKT)
Mercer International (MERC)
Screaming Eagle Acquisitn Class A Ord Shs (SCRM)
Sage Therapeutics (SAGE)
Alibaba Group Hldg Sponsored Ads (BABA)
Imperial Oil Com New (IMO)

View all positions for Cowen And Company

Top funds holding Biohaven

Stifel Financial
Henderson Group
T. Rowe Price Associates
Point72 Asset Management
Perceptive Advisors
Vanguard Group
Redmile Group
Holocene Advisors
Citadel Advisors
Avidity Partners Management
Bellevue Group
Goldman Sachs Group
Oracle Investment Management
A.R. Schmeidler & Co
Charles Schwab Investment Management

View all funds holding Biohaven